Vedolizumab in the treatment of chronic, antibiotic‐dependent or refractory pouchitis

201781 citationsJournal Articlebronze Open Access

Authors

Our data indicate that vedolizumab could be an option in the treatment of patients with chronic, antibiotic-dependent or refractory pouchitis.

Good health and well-being

Published in: Alimentary Pharmacology & Therapeutics

Volume 47, Issue 5, pp. 581-587

Field-Weighted Citation Impact: 8.74